|
Cayman Islands
(State or other jurisdiction of
incorporation or organization) |
| |
Not Applicable
(I.R.S. Employer
Identification Number) |
|
|
Exhibit
Number |
| |
Description
|
|
|
1.1*
|
| | Form of Underwriting Agreement | |
|
4.1
|
| | | |
|
4.2
|
| | Registrant’s Specimen of Ordinary Share Certificate (incorporated by reference to Exhibit 4.1 to the registration statement on Form F-1 (File No. 333-234356), as amended, initially filed with the Securities and Exchange Commission on October 28, 2019) | |
|
4.3
|
| | Form of Deposit Agreement by and among the Registrant, the depositary and the holders and beneficial owners of the American Depositary Receipts issued thereunder (incorporated by reference to Exhibit 1 to the registration statement on Form F-6 (File No. 333-234510), filed with the Securities and Exchange Commission on November 5, 2019) | |
|
4.4*
|
| | Certificate of Designation for Preferred Shares | |
|
4.5*
|
| | Registrant’s Specimen of Warrant Certificate | |
|
4.6*
|
| | Form of Warrant Agreement | |
|
4.7*
|
| | Form of Indenture | |
|
4.8*
|
| | Form of Debt Security | |
|
4.9*
|
| | Form of Subscription Rights Agreement | |
|
4.10*
|
| | Form of Subscription Rights Certificate | |
|
4.11*
|
| | Specimen Unit Certificate | |
|
5.1†
|
| | | |
|
8.1†
|
| | | |
|
8.2†
|
| | | |
|
23.1**
|
| | | |
|
23.2†
|
| | | |
|
23.3†
|
| | | |
|
24.1†
|
| | | |
|
107†
|
| | |
|
Signature
|
| |
Title
|
|
|
/s/ Nangeng Zhang
Name: Nangeng Zhang
|
| |
Chairman and Chief Executive Officer (principal executive officer)
|
|
|
*
Name: Wenjun Zhang
|
| |
Independent Director
|
|
|
*
Name: Hongchao Du
|
| |
Independent Director
|
|
|
*
Name: Zhitang Shu
|
| |
Independent Director
|
|
|
*
Name: Yaping Zhang
|
| |
Independent Director
|
|
|
*
Name: James Jin Cheng
|
| |
Chief Financial Officer
|
|
|
*
Name: Lu Meng
|
| |
Secretary to the Board
|
|
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated April 17, 2024, with respect to the consolidated financial statements of Canaan Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/KPMG Huazhen LLP
Beijing, China
September 3, 2024